Tymlos

Drug List

Tymlos

Drug Name

Tymlos (Abaloparatide)

Manufactured By

Radius Health, Inc

Drug Savings

Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.

NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

Treats Disease/Condition

Uses

Indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, It reduces the risk of vertebral fractures and non-vertebral

How To Use

Administer Tymlos as a subcutaneous injection into the periumbilical region of the abdomen. Rotate the site of the injection every day and administer at approximately the same time every day. Do not administer intravenously or intramuscularly. Administer the first several doses where the patient can sit or lie down if necessary, in case symptoms of orthostatic hypotension occur [see Tymlos is a clear and colorless solution. Visually inspect Tymlos for particulate matter and discoloration prior to administration. Do not use if solid particles appear or if the solution is cloudy or colored. Provide appropriate training and instruction to patients and caregivers on the proper use of the Tymlos pen.

Side Effects

* Orthostatic Hypotension * Hypercalcemia * Hypercalciuria and Urolithiasis

Drug Interactions

No specific drug-drug interaction studies have been performed

In Case of Overdose

There is no specific antidote for Tymlos. Treatment of suspected overdose should include discontinuation of Tymlos, monitoring of serum calcium and phosphorus, and implementation of appropriate supportive measures, such as hydration. Based on the molecular weight, plasma protein binding and volume of distribution, abaloparatide is not expected to be dialyzable.

In Case of Missed Dose

If you forget or cannot take TYMLOS at your usual time, take it as soon as you can on that day.

Storage

Before first use: Refrigerate between 2-8°C (36-46°F) After first use: Store for up to 30 days at 20-25°C (68-77°F) Do not freeze or subject to heat